6-Chloroflavone

6-Chloroflavone

SCHEMBL4649891

O=c1cc(-c2ccccc2)oc2ccc(Cl)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 4/20 1.00
ADORA3 P0DMS8 2/20 1.00
GABRP O00591 12/20 0.80
GABRD O14764 12/20 0.80
GABRA1 P14867 12/20 0.80
GABRB1 P18505 12/20 0.80
GABRG2 P18507 12/20 0.80
GABRB3 P28472 12/20 0.80
GABRA5 P31644 12/20 0.80
GABRA3 P34903 12/20 0.80
GABRA2 P47869 12/20 0.80
GABRB2 P47870 12/20 0.80
GABRA4 P48169 12/20 0.80
GABRE P78334 12/20 0.80
GABRA6 Q16445 12/20 0.80
GABRG1 Q8N1C3 12/20 0.80
GABRG3 Q99928 12/20 0.80
GABRQ Q9UN88 12/20 0.80
PLA2G2A P14555 2/20 0.73
PLA2G4A P47712 2/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
6-Chloroflavone SCHEMBL7030912 0.93 TNKS (0.86) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL4650588 0.90 GABRP (0.82) TNKSADORA3GABRPGABRDGABRA1
7-Chloroflavone SCHEMBL12940670 0.87 TNKS (0.77) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL12941631 0.84 NPC1 (0.77) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL24227286 0.83 PLA2G2A (0.97) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL28100458 0.82 PLA2G2A (0.76) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL30000854 0.82 TNKS (0.69) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL4650655 0.82 TNKS (1.00) TNKSADORA3GABRPGABRDGABRA1
SCHEMBL6907832 0.81 GABRP (0.74) TNKSADORA3GABRPGABRDGABRA1
Flavone SCHEMBL18879 0.81 TNKS (1.00) TNKSADORA3GABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
WO-2015129813-A1 DEUTERATION METHOD AND DEUTERATION CATALYST 国立大学法人 長崎大学 2015-09-03 WO disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
CN-102140087-B Synthetic method for chromone compound UNIV TSINGHUA 2013-02-13 CN disclosed
US-20110230523-A1 TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF PARATEK PHARMACEUTICALS, INC. (US) 2011-09-22 US disclosed
CN-102140087-A Synthetic method for chromone compound UNIV TSINGHUA 2011-08-03 CN disclosed
US-20090131401-A1 Transcription factor modulating compounds and methods of use thereof PARATEK PHARMACEUTICALS, INC. (US) 2009-05-21 US disclosed
US-20090131401-A1 Transcription factor modulating compounds and methods of use thereof PARATEK PHARMACEUTICALS, INC. (US) 2009-05-21 US disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-7405235-B2 Transcription factor modulating compounds and methods of use thereof PARATEK PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed
US-7405235-B2 Transcription factor modulating compounds and methods of use thereof PARATEK PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131401-A1 Transcription factor modulating compounds and methods of use thereof JUN, CREBBP, TFEB TNKS 1140/4885ADORA3 4693/4885GABRP 1579/4885
US-20110230523-A1 TRANSCRIPTION FACTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF JUN, CREBBP, TFEB TNKS 1140/4885ADORA3 4693/4885GABRP 1579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.